LncRNA PVT1 (plasmacytoma variant translocation 1) has become a staple of the lncRNA
profile in patients with renal cell carcinoma (RCC). Common dysregulation in renal tumors …

Despite significant progress regarding clinical detection/imaging evaluation modalities and
genetic/molecular characterization of pathogenesis, advanced renal cell carcinoma (RCC) …

Renal cell carcinoma (RCC) is one of the most frequent malignant neoplasms of the kidney.
The therapeutic options available for the treatment of advanced or metastatic RCC include …

Background/Aim: We previously described four different vascular patterns (reticular, diffuse,
fasciculate, and trabecular) in renal cell carcinoma (RCC) suggesting an early and …

Renal cell cancer (RCC) is a heterogeneous tumor that shows both intra-and inter-
heterogeneity. Heterogeneity is displayed not only in different patients but also among RCC …

The identification of new prognostic markers of renal cell carcinoma (RCC) is an urgent
problem in oncourology. To investigate the potential prognostic significance of tumor …

Introduction: End-stage renal disease (ESRD) and acquired cystic kidney disease (ACKD)
are known risk factors for renal cell carcinoma (RCC). Hereby, the clinicopathological …

Circular RNAs (circRNAs) are linked with the occurrence and progression of renal cell
carcinoma (RCC). However, circRNAs' mechanism in developing resistance to RCC has not …

We reported an 85-year-old patient with malignant glomus tumor (GT) of the prostate. He
presented with urinary frequency for more than 2 years and gross hematuria for 7 days …

Simple Summary The latest World Health Organization classification for kidney tumors,
released in 2022, brings important changes, introducing new types of tumors and refining …